Josh Richardson - Profile and Investment Details

Investor Profile

Josh Richardson is a Venture Capital based in Greenwich, United States with a diverse investment portfolio that includes companies such as Zavante Therapeutics, CardioDx, WelbeHealth, Velicept Therapeutics, Esperion Therapeutics, Aptus Endosystems, Cydan, Jazz Pharmaceuticals, Eargo, Orbus Therapeutics, LEXEO Therapeutics, RxSight, InfaCare Pharmaceutical, Aptinyx, Somatus, Talaris Therapeutics, KaNDy Therapeutics, Dascena, Venus Concept, Epirium Bio, Axonics Modulation Technologies, Tricida, Practice Fusion, Amphora Medical, Neurana Pharmaceuticals, Collegium Pharmaceutical, Sublimity Therapeutics, Rapid Micro Biosystems, Velomedix, Polares Medical, PixelOptics, Vera Therapeutics, Checkmate Pharmaceuticals, Vaxcyte, CuraSen Therapeutics, Civitas Therapeutics, Solta Medical, Alphaeon, Amunix, BAROnova, Poseida Therapeutics, Molecular Templates, Helomics, Sympara Medical, PreCision Dermatology, Tiburio Therapeutics, Corcept Therapeutics, Aimmune Therapeutics, MURJ, 89bio, Inozyme, AqueSys, Kala Pharmaceuticals, Encore Dermatology, Whitehill Technologies, Endeavor BioMedicines. Over time, Josh Richardson has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Josh Richardson is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Wearables, Women Founded, Medical Testing, Women Led, Life Science, Information Technology (IT), Biotech, Medical Device, Software, Healthcare, Biotechnology, Market Research, Consumer Software, Audio, Health Diagnostics, Travel, Medical, Therapeutics, Developer Platform, Pharmaceuticals may find it worthwhile to explore potential connections with Josh Richardson, as their portfolio suggests a familiarity and interest in this area.

Understanding Josh Richardson’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.